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A potential link between the measles-mumps-rubella vaccine and autism was dismissed by a
federal vaccine court in February 2009. The U.S. Department of Health and Human Services
said the findings demonstrate a lack of medical evidence for any association, while Autism
Speaks, a patient advocacy group, said questions remain about potential risks for certain
subgroups.
Other legal actions are pending as the scientific and patient advocacy communities
debate the need to conduct further research on the vaccine-autism link. Meanwhile, public
health advocates worry that continuing concerns about the safety of vaccines may depress
the population immunization rate. A small rise in reported measles cases may be linked to
exemptions that allow families to opt out of vaccine mandates.
This paper reviews the scientific research on vaccines and autism, the legal decisions to
date, and the importance of continued attention to vaccine safety and maintaining public
confidence in childhood vaccinations.
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On Feb. 12, 2009, the U.S. Court of Federal Claims, acting under the authority of the
National Vaccine Injury Compensation Program, unanimously ruled that the plaintiffs had not
demonstrated a causal link between autism and the combination of the measles/mumps/rubella
(MMR) vaccine and vaccines containing the preservative thimerosal.1
The U.S. Department of Health and Human Services responded with the following
statement: “The medical and scientific communities have carefully and thoroughly reviewed the
evidence concerning the vaccine-autism theory and have found no association between vaccines
and autism.”2
But the decisions did not end the debate. Autism Speaks, a nonprofit advocacy organization
that funds biomedical research and raises public awareness about autism, continues to
urge further study. Advocates believe questions remain about “whether certain subgroups of
individuals with particular underlying medical or genetic conditions may be more vulnerable to
adverse effects of vaccines.”3
In a further development, another case returned to public attention in late February 2009,
after a financial settlement was announced with the family of an injured boy. In that decision,
issued in 2007, the Court of Claims had concluded that the MMR vaccine had triggered
a seizure in a 15-month-old boy, which in turn led a neurological disorder that resulted in
“pervasive developmental delay.” Pervasive developmental delay “refers to the class of conditions
to which autism belongs.”4
Thus, while the court had dismissed a causal link between vaccines and autism in the three
test cases announced in early February, this ruling and others suggests that in very rare cases
MMR can trigger conditions that share the features of autism.
This paper reviews several key court decisions, the body of research addressing the question
of vaccines and autism, and the implications for broader questions of vaccine safety.

The role of the vaccine court
The National Vaccine Injury Compensation Program, enacted by Congress in 1986, was
created to provide a no-fault alternative to traditional fault-based litigation. In establishing
a compensation program, the law in essence acknowledges that despite their profound and
overwhelming value to society, vaccines, like any medical intervention, carry some level of risk.
By establishing a no-fault compensation system, Congress sought to prevent an exit from the
vaccine market by manufacturers concerned about their liability exposure, while also promoting
greater focus on safety research.
Claimants under the program, which is funded through a special tax on vaccines, are not
required to prove negligence. A cause-and-effect relationship is assumed if certain listed injuries
or medical conditions occur within a prescribed period of time following vaccination. If other
injuries or conditions occur, the injured person must demonstrate that a “preponderance of
evidence” proves a relationship between the condition and the immunization.
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The claims relating to vaccines and autism involved injuries that were not on the formal
injury schedule, and thus had to be proved by a preponderance of evidence.

Origins of autism-related vaccine safety concerns
The potential link between the MMR vaccine and autism dates back to 1998, when a Lancet
study associated symptoms of gastrointestinal disorders with developmental regression.5 Parents
reported that the symptoms seemed to have begun within a month of vaccination, and the
British authors hypothesized that intestinal inflammation caused by the vaccine may have
unleashed peptides capable of traveling through the bloodstream and into the brain, where they
interfered with normal infant development.
The hypothesis linking thimerosal to autism has its roots in a joint recommendation by the
American Academy of Pediatrics (AAP) and the U.S. Public Health Service that mercury be
removed from vaccines administered to infants.6 That statement came after the Food and Drug
Administration (FDA) determined that immunizations might expose infants to cumulative doses
of mercury above some federal safety guidelines. Thimerosal is comprised of about 50 percent
mercury by weight, and although the AAP and the Public Health Service took pains to
emphasize the significant safety margin built into mercury exposure limits,7 concerns grew that
elevated exposure was somehow linked to autism.
Questions about vaccines generated extensive media attention over the next several years,
especially in Great Britain, where the MMR vaccine became “the biggest science story of the
year” by 2002, according to a Guardian reporter.8 Within a few years, MMR vaccination rates in
Great Britain fell from 92 percent to below 80 percent.9 While the response to the controversy
was more subdued in the United States, a small but vocal group of U.S. parents also began to
opt out of immunization school entry requirements.

The scientific evidence
In 2004, 10 of the 13 authors on the 1998 Lancet paper published a partial retraction: “We
wish to make it clear that in this paper no causal link was established between MMR vaccine
and autism … . However, the possibility of such a link was raised … . We consider now is the
appropriate time that we should together formally retract the interpretation placed upon these
findings … .”10
Over the past decade, the scientific community has conducted substantial research — most
of it government-funded — to test the hypothesis that the MMR vaccine has a causal link to
autism. The body of evidence is consistent in its failure to demonstrate such a link:
➤➤

The Immunization Safety Review Committee, part of the Institute of Medicine,
reviewed relevant scientific studies, looking both for a plausible biological mechanism
that might explain the connection and epidemiological evidence to support it.

The Committee concluded in 2004 “that the body of epidemiological evidence favors
rejection of a causal relationship between the MMR vaccine and autism. The committee also
concludes that the body of epidemiological evidence favors rejection of a causal relationship
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between thimerosal-containing vaccines and autism. The committee further finds that potential
biological mechanisms for vaccine-induced autism that have been generated to date are
theoretical only.”6
➤➤
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In January 2009, the Centers for Disease Control and Prevention (CDC) summarized
ten ongoing or completed studies that it had supported.11 Among them:
➣➣

The Danish Medical Research Council, through a cooperative agreement with
the CDC, conducted a seven-year retrospective study of more than 500,000
children (all children born in Denmark from 1991 through 1998) and “found no
association between the MMR vaccination and autism.”12

➣➣

Two groups of Italian infants were given two different versions of the diphtheria/
pertussis/tetanus vaccine in 1992–93, one containing thimerosal, one without it,
and then followed to ages 10–12. “The weak and inconsistent association found
in this study suggests that the association between thimerosal exposure through
vaccination in infancy and neuropsychological deficits is unlikely or clinically
negligible,” according to the authors.13

➣➣

From 2003–05, researchers searched for measles virus in bowel tissue taken
from children with autism and gastrointestinal disorders and from children
with gastrointestinal disorders alone. The study addressed one of the principal
claims raised by plaintiffs in the recent vaccine court cases and echoed the work
described in the 1998 Lancet paper that first triggered concern. The authors
concluded that the results are “inconsistent with a causal role for MMR vaccine
as a trigger or exacerbator of either GI [gastrointestinal] difficulties or autism.”14

Despite this research, a number of advocacy groups assert that a link between vaccines
and autism has not been ruled out. In particular, they believe more data are needed to identify
potential vaccine safety risks among certain sub-populations of children.
“Fundamental questions have not been addressed, such as whether the use of combination
vaccines confers increased risk for adverse events and whether there are subgroups in the
general population, such as children with certain genetic or metabolic conditions that are more
vulnerable to serious adverse effects of vaccines, including [autism],” said a spokesperson for
Autism Speaks.15

The Bailey Banks decision and the Hannah Poling settlement
Two vaccine court decisions involving injury claims related to the MMR vaccine generated
particular concern about safety.
The case of Bailey Banks, decided in 2007, earned renewed media attention in February
2009 after the government reached a financial settlement with the child’s family. In its decision,
the court found that 15-month-old Bailey had a seizure following administration of the MMR
vaccine, and developed a neurological disorder known as acute disseminated encephalomyelitis.
That condition, in turn, led to “pervasive developmental delay not otherwise specified.”
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PDDNOS, according to the court, “is a subthreshold condition in which some — but not all —
features of autism … are identified.”4
There was no evidence that Bailey Banks had an underlying medical condition prior to being
vaccinated. The advocacy group Generation Rescue ran a full-page ad in USA Today about the
case, quoting the vaccine court decision and calling on the government to tell “the truth about
childhood vaccines.”16
In another case, settled in February 2008, the court had also acknowledged harm done by
vaccines, ruling that the family of an injured girl named Hannah Poling was entitled to compensation under the National Vaccine Injury Compensation Program.17
After receiving five vaccinations during a single doctor’s visit, at 19 months of age, Hannah
was diagnosed with a mitochondrial enzyme deficiency, characterized in part by regression in a
child who had appeared to be developing normally. The court concluded that the case had met
“the statutory criteria for demonstrating that the vaccinations [the] CHILD received on July
19, 2000 significantly aggravated an underlying mitochondrial disorder, which predisposed her
to deficits in cellular energy metabolism, and manifested as a regressive encephalopathy with
features of autism spectrum disorder.”18 The court’s observation that vaccines had aggravated an
underlying mitrochondrial disorder was significantly different from concluding that vaccines had
caused it.
Different parties interpreted the Poling settlement substantially differently. The Poling family and many advocacy groups believed it offered clear support for a link between vaccines and
autism in vulnerable populations. Hannah’s father, Jon S. Poling, who is also a neurologist, wrote
“Many in the autism community and their champions believe that the result in this case may well
signify a landmark decision as it pertains to children developing autism following vaccinations.
This still remains to be seen.” He called for “an immunization database for children with metabolic disorders to establish safety guidelines and improve vaccine safety for minority subgroups of
children.”19
Others disagreed, arguing that the basis of the settlement was “poorly reasoned” and that
“features of autism spectrum disorder” are evident in most children with profound cognitive impairment and can differ significantly from classic autism.20
But the bottom line in these cases appears to be that vaccines did cause severe adverse reactions, resulting in conditions with autism-like features.

Vaccine court test cases
Claims that childhood vaccinations had caused, or contributed to, autism mounted through
the first decade of the 21st century. By Feb. 1, 2009, more than 5,500 requests for compensation related to autism claims had been filed with the National Vaccine Injury Compensation
Program. The Office of Special Masters, established within the U.S. Court of Federal Claims
to adjudicate vaccine claims, developed a process for reviewing and judging these claims as a
group.21 (Special Masters are attorneys appointed by the court to hear complex cases raising
voluminous facts.)
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The decisions announced Feb. 12, 2009 involved three test cases, heard by three Special
Masters, of the theory that MMR vaccines and thimerosal-containing vaccines could combine
to cause autism.
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The first test case hypothesized the following causation theory: thimerosal-containing
vaccines weaken the immune system of certain children, thereby permitting the measles virus
contained in the MMR vaccine to persist. The persisting virus thus damaged the digestive
system and brain, causing autism, mental retardation and seizures.22 The other two test cases
offered variations on this basic theory.
The Special Masters issued their decisions in the three cases after reviewing clinical studies,
large epidemiologic studies designed to measure an associational link between autism and
child immunization, and the medical records of the children involved. The evidentiary record
included almost 5,000 pages of transcripts and more than 700 pages of post-hearing briefs.
There were 939 medical articles, 50 expert reports and testimony from 28 experts (by contrast,
a typical vaccine case presents about 10 articles and six or fewer experts). To reach their
conclusions, the Special Masters had to consider knowledge contained in many subspecialties
of biology and medicine, including neurology, gastroenterology, virology, immunology, molecular
biology, toxicology, genetics, and epidemiology.22
The language in the decisions was deeply sympathetic to the families. “[Michelle’s] family
members clearly have done a wonderful job of coping with Michelle’s conditions, and in caring
for her with great love. I admire them greatly,” wrote one Special Master. “Certainly the mere
fact that Michelle’s autistic symptoms first became evident to her family during the months
after her MMR vaccination might make them wonder about a possible causal connection.”22
Nonetheless, the final decision was unqualified. As the Special Master wrote, this case “is
not a close case. The overall weight of the evidence is overwhelmingly contrary to the petitioners’
causation theories … . This is a case in which the evidence is so one-sided that any nuances in
the interpretation of the causation case law would not make a difference to the outcome of the
case.”22
A decision on a second theory, also being examined in three test cases — that thimerosalcontaining vaccines alone can cause autism — is expected in late spring or early summer 2009.
Regardless of the conclusion, the autism cases are unlikely to end quickly. Although the
Vaccine Injury Compensation Program is intended to be the first place injured parties seek
compensation, the law also allows them to claim negligence and pursue traditional avenues of
litigation.23 All three sets of parents in the three test cases have said they will go to civil court to
present their claims as negligence cases.9

The direction of further research
As legal arguments continue, the importance of a robust vaccine safety research agenda comes
into sharper focus. Vaccine mandates rank among the most important tools in the public health
arsenal, because they create a “herd immunity” for the general population, and particularly for
vulnerable children, including children with special health needs who cannot be immunized
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and infants too young to be immunized. But as Congress recognized when it created the
Vaccine Injury Compensation Program, the compulsory nature of immunizations confers a
special obligation on society to assure families that vaccines are as safe as possible.
Public trust is the linchpin of effective population-wide immunization, best achieved by
more vigorous investments in immunization-safety science and improved communication
strategies. “No one claims ‘zero risk’ for the vaccines against 16 diseases that are currently
recommended to protect children in the United States,” write the authors of a recent Pediatrics
article, emphasizing the importance of “research on the short- and longer-term risks and
benefits of combinations and timing of multiple vaccines … . Immunization-safety science
requires leadership, infrastructure, facilities and human resources, and appropriate long-range
planning and funding.”24
Further research is also needed into autism, and other conditions that feature the severe
developmental delays characteristic of autism.
However, the IOM’s Immunization Safety Review Committee has concluded that significant
investment into the “theoretical vaccine-autism connection [is not] useful at this time.”6 Recent
action by the Interagency Autism Coordinating Committee also seems to support the notion
that additional efforts to explore the vaccine-autism link itself are not a priority. Under the
Combating Autism Act, the committee was established within the Department of Health and
Human Services to guide the nation’s autism research agenda.25 In January 2009, members
voted to remove two objectives related to vaccine safety research from its strategic plan.26
This action disappointed the advocacy community, which had been consulted as the
strategic plan was drafted and had supported those objectives. Protesting both the process by
which the decision was made, and the merits of the change itself, Autism Speaks withdrew its
support from the plan.27
Duane Alexander, MD, director of the National Institute of Child Health and Human
Development, a part of the NIH, was the only federal government member of the Coordinating
Committee to abstain from the vote on that decision. In an interview with Autism Speaks, he
said, “One question that still remains to be addressed in a study of adequate size and precision
is … whether there is a subgroup in the population that, on a genetic basis, is more susceptible
to some vaccine characteristic or component than most of the population, and may develop an
ASD [autism-spectrum disorder] in response to something about vaccination.”28

Vaccines and public confidence
As the debate continues, the merits of the vaccine-autism claim, and concerns over vaccine
safety more generally, influence the willingness of some parents to vaccinate their children.
The measles/mumps/rubella, diphtheria/pertussis/tetanus, and polio vaccines are almost
universally required for school-age American children, and more than 95 percent of them
are inoculated.29 But all states allow exemptions to the requirements on medical grounds: 48
states allow religious exemptions, and 21 provide “personal-belief” exemptions, which vary in
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their flexibility from state to state.30 A small, but growing, number of “vaccine skeptics” have
requested these exemptions for their children.31 Public concern is also apparent in the response
to a national survey in which almost one-quarter of adults said that a potential link to autism
meant it was safer not to vaccinate children.32
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Meanwhile, measles, a highly infectious respiratory disease that can occasionally cause
complications that include pneumonia, encephalitis, seizures, and death, is on the rise. From
January to July 2008, 131 cases were reported, compared to an average of 63 cases every year
from 2000 through 2007, according to the CDC, which warns, “the findings demonstrate that
measles outbreaks can occur in communities with a high number of unvaccinated persons.”33
Any lessening of the herd immunity conferred by widespread use of the vaccine puts at risk
those individuals who do not respond fully to its protective shield, or can not be vaccinated for
medical reasons.
Because measles is one of the first diseases to reappear when vaccination coverage rates fall,
it is also something of a “canary in a mine,” possibly heralding the return of other preventable
childhood diseases. Complications of those diseases, while often avoidable if good health care is
readily available, can be significant — mumps can lead to meningitis and permanent deafness,
rubella can cause birth defects in pregnant women, untreated diphtheria can lead to coma and
death.34
Most public health experts believe any drop in vaccination rates is an unintended
consequence of a success story. “Many people don’t know what vaccine-preventable childhood
diseases even look like, or how dangerous they can be,” says Alexandra Stewart, JD, assistant
research professor in the Department of Health Policy at The George Washington University’s
School of Public Health and Health Services. “Vaccines are one of the greatest public advances
we have achieved as a society.”
Public health can play an important role in sustaining that success. One study, for example,
showed that providing in-service training and resource materials to nurses increased the amount
of time they spent talking to their patients about vaccines.35 Public health educators can also
help to guide Americans to current, science-based information that addresses their legitimate
concerns about safety.36
Vaccines are mandatory because they confer vital public health protections. But that
mandate also confers special obligations on the government. The Vaccine Injury Compensation
Program recognizes the importance of minimizing risk with robust investments in safety
research, and compensation for families when injuries associated with vaccines do occur. While
the February 2009 decisions find no causal link between MMR vaccines and autism, a strong
and transparent safety research agenda and the energetic education of both parents and health
care professionals, is essential to sustain and enhance public trust in vaccines.
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